A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome

NCT03569631 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Fragile X Syndrome
FXS
Fra(X) Syndrome

Interventions

DRUG: BPN14770
DRUG: Placebo

Sponsor

Tetra Discovery Partners